Sanofi SNY
NASDAQ SNY
$41.60 -0.36 (-0.86%)
At close: Oct 23, 2026 · 4:00 PM EDT

Sanofi (SNY) Income towards Parent Company (2009 - 2026)

Updated

Sanofi (SNY) posted Income towards Parent Company of $438.21 million for the quarter ended Jun 30, 2026, down 90.2% from $4.46 billion a year earlier and down 76.9% from the prior quarter.

Analysis

Sanofi (SNY) Income towards Parent Company (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Income towards Parent Company at Sanofi was $2.38 billion, down 76.5% year-over-year; for the year ended Dec 31, 2025, it came in at $8.83 billion, up 45.2% from the prior year.

  • Annual Income towards Parent Company shows a five-year compound annual growth rate of -8.9% (years ended Dec 2020 to Dec 2025).
  • In prior years, Sanofi's Income towards Parent Company was $6.08 billion in the year ended Dec 31, 2024 (+4.1%), $5.84 billion in the year ended Dec 31, 2023 (-34.7%), $8.94 billion in the year ended Dec 31, 2022 (+20.3%) and $7.43 billion in the year ended Dec 31, 2021 (-47.2%).
  • Quarterly Income towards Parent Company has run from a low of -$10.06 billion in the quarter ended Dec 31, 2025 to a high of $10.11 billion in the quarter ended Sep 30, 2025 over five years.
  • On a year-over-year basis, Income towards Parent Company increased in four of the last six quarters, with growth averaging 78.8%.
  • The strongest year-over-year quarter for Income towards Parent Company in the past five years was the quarter ended Jun 30, 2025, with growth of 271.1%; the weakest was the quarter ended Jun 30, 2026, with a decline of 90.2%.
  • According to Business Quant data, Income towards Parent Company for the three prior quarters was $1.9 billion (quarter ended Mar 31, 2026), -$10.06 billion (quarter ended Dec 31, 2025) and $10.11 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Sanofi 50.73 Bn 17.66 Bn 10.79 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 398.69 Mn
Mar 31, 2026 1.89 Bn
Dec 31, 2025 -7.70 Bn
Sep 30, 2025 10.07 Bn
Jun 30, 2025 4.46 Bn
Mar 31, 2025 1.97 Bn
Dec 31, 2024 533.23 Mn
Sep 30, 2024 3.09 Bn
Jun 30, 2024 1.20 Bn
Mar 31, 2024 1.23 Bn
Dec 31, 2023 -597.15 Mn
Sep 30, 2023 2.75 Bn
Jun 30, 2023 1.56 Bn
Mar 31, 2023 2.14 Bn
Dec 31, 2022 3.17 Bn
Sep 30, 2022 2.09 Bn
Jun 30, 2022 1.25 Bn
Mar 31, 2022 2.25 Bn
Dec 31, 2021 1.29 Bn
Sep 30, 2021 2.72 Bn
API Access

Sanofi Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=SNY&period=max&api_key=YOUR_API_KEY